Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Surgery Today
Erschienen in: Surgery Today 3/2021

10.07.2020 | Review Article

Surgical management of thymic epithelial tumors

verfasst von: Yasushi Shintani, Soichiro Funaki, Naoko Ose, Takashi Kanou, Eriko Fukui, Kenji Kimura, Masato Minami

Erschienen in: Surgery Today | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Resection is the mainstay of treatment for thymic epithelial tumors (TETs), with complete removal of the tumor and involved organs being the ultimate aim. The choice of surgical approach plays a major role in defining treatment success, and the optimal choice of method should thus provide an adequate surgical view to achieve complete tumor resection. While median sternotomy is considered the gold standard for access to the mediastinum, several minimally invasive approaches to thymectomy have been described, including video-assisted robotic-assisted thymectomy, although the oncological outcomes of that procedure remain unclear. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve resectability and outcomes for patients with advanced TETs. Surgical debulking is also reportedly acceptable for invasive thymoma because of its potential for achieving favorable outcomes. Re-resection is an acceptable option for patients with recurrent thymoma after initial resection, and repeat resection for recurrent pleural dissemination seems effective. Here, the literature on current clinical practices in the surgical management and treatment of TETs is reviewed.
Literatur
1.
Kondo K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62(8):468–74 (Epub 2014/06/11).PubMed
2.
Weis CA, Yao X, Deng Y, Detterbeck FC, Marino M, Nicholson AG, et al. The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol. 2015;10(2):367–72 (Epub 2015/01/24).PubMedPubMedCentral
3.
Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383–95 (Epub 2015/08/22).PubMedPubMedCentral
4.
Galateau-Salle F, Churg A, Roggli V, Travis WD. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11(2):142–54 (Epub 2016/01/27).PubMed
5.
Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485–92 (Epub 1981/12/01).PubMed
6.
Detterbeck FC, Asamura H, Crowley J, Falkson C, Giaccone G, Giroux D, et al. The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol. 2013;8(12):1467–73 (Epub 2014/01/07).PubMed
7.
Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15(1):82–92 (Epub 2015/09/27).PubMed
8.
Ruffini E, Venuta F. Management of thymic tumors: a European perspective. J Thorac Dis. 2014;6(Suppl 2):S228–S23737 (Epub 2014/05/29).PubMedPubMedCentral
9.
Chen J, Yang Y, Zhu D, Chen G, Wei S, Qiu X, et al. Thymoma with pure red cell aplasia and Good's syndrome. Ann Thorac Surg. 2011;91(5):1620–2 (Epub 2011/04/29).PubMed
10.
Christakis I, Qiu W, Silva Figueroa AM, Hyde S, Cote GJ, Busaidy NL, et al. Clinical features, treatments, and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia type 1 syndrome at MD Anderson Cancer Center. Hormones Cancer. 2016;7(4):279–87 (Epub 2016/06/18).PubMed
11.
Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76(3):878–84 (discussion 84–5, Epub 2003/09/10).PubMed
12.
Kondo K. Optimal therapy for thymoma. J Med Investig. 2008;55(1–2):17–28 (Epub 2008/03/06).
13.
Marom EM, Rosado-de-Christenson ML, Bruzzi JF, Hara M, Sonett JR, Ketai L. Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma. J Thorac Oncol. 2011;6(7 Suppl 3):S1717–S17231723 (Epub 2011/09/29).PubMed
14.
Lee JH, Park CM, Park SJ, Bae JS, Lee SM, Goo JM. Value of computerized 3D shape analysis in differentiating encapsulated from invasive thymomas. PLoS ONE. 2015;10(5):e0126175 (Epub 2015/05/06).PubMedPubMedCentral
15.
Broncano J, Alvarado-Benavides AM, Bhalla S, Alvarez-Kindelan A, Raptis CA, Luna A. Role of advanced magnetic resonance imaging in the assessment of malignancies of the mediastinum. World J Radiol. 2019;11(3):27–45 (Epub 2019/04/06).PubMedPubMedCentral
16.
Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, et al. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Eur J Cardiothorac Surg. 2012;42(6):e152–e156156 (Epub 2012/10/02).PubMed
17.
Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N. The role of [(1)(8)F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors. Cancer Imaging. 2011;11:195–201 (Epub 2011/12/06).PubMedPubMedCentral
18.
Drevet G, Collaud S, Tronc F, Girard N, Maury JM. Optimal management of thymic malignancies: current perspectives. Cancer Manag Res. 2019;11:6803–14 (Epub 2019/08/16).PubMedPubMedCentral
19.
Shintani Y, Funaki S, Ose N, Kanou T, Fukui E, Minami M. Surgical approach for thymic epithelial tumor. J Thorac Dis. 2019;11(8):E127–E130130 (Epub 2019/09/29).PubMedPubMedCentral
20.
Limmer S, Merz H, Kujath P. Giant thymoma in the anterior-inferior mediastinum. Interact Cardiovasc Thorac Surg. 2010;10(3):451–3 (Epub 2009/12/31).PubMed
21.
Fujiwara A, Funaki S, Ose N, Kanou T, Kanzaki R, Minami M, et al. Surgical resection for advanced thymic malignancy with pulmonary hilar invasion using hemi-clamshell approach. J Thorac Dis. 2018;10(12):6475–81 (Epub 2019/02/13).PubMedPubMedCentral
22.
Masaoka A, Ito Y, Yasumitsu T. Anterior approach for tumor of the superior sulcus. J Thorac Cardiovasc Surg. 1979;78(3):413–5 (Epub 1979/09/01).PubMed
23.
Haruki T, Wakahara M, Taniguchi Y, Nakamura Y, Nishimura M, Nakamura H. Successful multimodality treatment for locally advanced primary thymic adenocarcinoma: report of a case. J Surg Case Rep. 2016;8:1–4 (Epub 2016/09/09).
24.
Ohta M, Hirabayasi H, Okumura M, Minami M, Matsuda H. Thoracoscopic thymectomy using anterior chest wall lifting method. Ann Thorac Surg. 2003;76(4):1310–1 (Epub 2003/10/08).PubMed
25.
Nakagiri T, Inoue M, Shintani Y, Funaki S, Kawamura T, Minami M, et al. Improved procedures and comparative results for video-assisted thoracoscopic extended thymectomy for myasthenia gravis. Surg Endosc. 2015;29(9):2859–65 (Epub 2014/12/10).PubMed
26.
Kido T, Hazama K, Inoue Y, Tanaka Y, Takao T. Resection of anterior mediastinal masses through an infrasternal approach. Ann Thorac Surg. 1999;67(1):263–5 (Epub 1999/03/23).PubMed
27.
Suda T, Hachimaru A, Tochii D, Maeda R, Tochii S, Takagi Y. Video-assisted thoracoscopic thymectomy versus subxiphoid single-port thymectomy: initial resultsdagger. Eur J Cardiothorac Surg. 2016;49(Suppl 1):i54–i5858 (Epub 2015/10/16).PubMed
28.
Rueckert J, Swierzy M, Badakhshi H, Meisel A, Ismail M. Robotic-assisted thymectomy: surgical procedure and results. Thorac Cardiovasc Surg. 2015;63(3):194–200 (Epub 2015/03/26).PubMed
29.
Suda T, Kaneda S, Hachimaru A, Tochii D, Maeda R, Tochii S, et al. Thymectomy via a subxiphoid approach: single-port and robot-assisted. J Thorac Dis. 2016;8(Suppl 3):S265–S271271 (Epub 2016/03/26).PubMedPubMedCentral
30.
Petersen RH. Video-assisted thoracoscopic thymectomy using 5-mm ports and carbon dioxide insufflation. Ann Cardiothorac Surg. 2016;5(1):51–5 (Epub 2016/02/24).PubMedPubMedCentral
31.
Ruckert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. J Thorac Cardiovasc Surg. 2011;141(3):673–7 (Epub 2011/02/22).PubMed
32.
Keijzers M, de Baets M, Hochstenbag M, Abdul-Hamid M, Zur Hausen A, van der Linden M, et al. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes. Eur J Cardiothorac Surg. 2015;48(1):40–5 (Epub 2014/09/23).PubMed
33.
Agatsuma H, Yoshida K, Yoshino I, Okumura M, Higashiyama M, Suzuki K, et al. Video-assisted thoracic surgery thymectomy versus sternotomy thymectomy in patients with thymoma. Ann Thorac Surg. 2017;104(3):1047–53 (Epub 2017/06/18).PubMed
34.
Kimura T, Inoue M, Kadota Y, Shiono H, Shintani Y, Nakagiri T, et al. The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg. 2013;44(3):e214–e218218 (Epub 2013/06/14).PubMed
35.
Okumura M, Yoshino I, Yano M, Watanabe SI, Tsuboi M, Yoshida K, et al. Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. 2019;56(1):174–81 (Epub 2019/02/21).PubMed
36.
Zhang X, Gu Z, Fang W. Minimally invasive surgery in thymic malignances: the new standard of care. J Thorac Dis. 2018;10(Suppl 14):S1666–S16701670 (Epub 2018/07/24).PubMedPubMedCentral
37.
Nakagawa K, Yokoi K, Nakajima J, Tanaka F, Maniwa Y, Suzuki M, et al. Is Thymomectomy alone appropriate for stage I (T1N0M0) thymoma? Results of a propensity-score analysis. Ann Thorac Surg. 2016;101(2):520–6 (Epub 2015/10/21).PubMed
38.
Onuki T, Ishikawa S, Iguchi K, Goto Y, Sakai M, Inagaki M, et al. Limited thymectomy for stage I or II thymomas. Lung Cancer. 2010;68(3):460–5 (Epub 2009/09/01).PubMed
39.
Shintani Y, Inoue M, Kawamura T, Funaki S, Minami M, Okumura M. Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution. Gen Thorac Cardiovasc Surg. 2015;63(3):159–63 (Epub 2014/10/15).PubMed
40.
Momozane T, Inoue M, Shintani Y, Funaki S, Kawamura T, Minami M, et al. Trimodality therapy for an advanced thymic carcinoma with both aorta and vena cava invasion. Ann Thorac Surg. 2016;102(2):e139–e141141 (Epub 2016/07/28).PubMed
41.
Rea F, Marulli G, Di Chiara F, Schiavon M, Perissinotto E, Breda C, et al. Multidisciplinary approach for advanced stage thymic tumors: long-term outcome. Lung Cancer. 2011;72(1):68–72 (Epub 2010/08/17).PubMed
42.
Wright CD, Choi NC, Wain JC, Mathisen DJ, Lynch TJ, Fidias P. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg. 2008;85(2):385–9 (Epub 2008/01/29).PubMed
43.
Furugen M, Sekine I, Tsuta K, Horinouchi H, Nokihara H, Yamamoto N, et al. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer. Jpn J Clin Oncol. 2011;41(8):1013–6 (Epub 2011/07/12).PubMed
44.
Fukuda M, Funaki S, Yamazaki T, Sato S, Mukae H, Takenoyama M, et al. S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: study protocol of LOGIK1605/JART-1501. Thorac Cancer. 2020;11(3):693–6 (Epub 2020/02/06).PubMedPubMedCentral
45.
Ose N, Inoue M, Morii E, Shintani Y, Sawabata N, Okumura M. Multimodality therapy for large cell neuroendocrine carcinoma of the thymus. Ann Thorac Surg. 2013;96(4):e85–e8787 (Epub 2013/10/04).PubMed
46.
Riely GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol. 2010;5(10 Suppl 4):S323–S326326 (Epub 2010/10/05).PubMed
47.
Okumura M, Miyoshi S, Takeuchi Y, Yoon HE, Minami M, Takeda SI, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 1999;117(3):605–13 (Epub 1999/02/27).PubMed
48.
Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, Minami M, et al. Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: a 20-year experience. Interact Cardiovasc Thorac Surg. 2019;28(3):360–7 (Epub 2018/09/27).PubMed
49.
Korst RJ, Bezjak A, Blackmon S, Choi N, Fidias P, Liu G, et al. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg. 2014;147(1):36–44 (6 e1, Epub 2013/10/22).PubMed
50.
Schmitt J, Loehrer PJ Sr. The role of chemotherapy in advanced thymoma. J Thorac Oncol. 2010;5(10 Suppl 4):S357–S360360 (Epub 2010/10/05).PubMed
51.
Yokoi K, Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol. 2007;2(1):73–8 (Epub 2007/04/06).PubMed
52.
Kobayashi Y, Fujii Y, Yano M, Sasaki H, Yukiue H, Haneda H, et al. Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action. Cancer. 2006;106(9):1901–7 (Epub 2006/04/07).PubMed
53.
Fujiwara A, Inoue M, Kusumoto H, Shintani Y, Maeda T, Okumura M. Myasthenic crisis caused by preoperative chemotherapy with steroid for advanced thymoma. Ann Thorac Surg. 2015;99(1):e11–e13 (Epub 2015/01/06).PubMed
54.
Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg. 2003;76(6):1866–72 (discussion 72, Epub 2003/12/12).PubMed
55.
Shintani Y, Kanzaki R, Kusumoto H, Nakagiri T, Inoue M, Okumura M. Pleuropneumonectomy for a large thymoma with multiple pleural dissemination using median sternotomy followed by posterolateral thoracotomy. Surg Case Rep. 2015;1(1):75 (Epub 2015/09/15).PubMedPubMedCentral
56.
Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg. 2006;82(4):1234–9 (Epub 2006/09/26).PubMed
57.
Okuda K, Yano M, Yoshino I, Okumura M, Higashiyama M, Suzuki K, et al. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan. Ann Thorac Surg. 2014;97(5):1743–8 (Epub 2014/03/25).PubMed
58.
Ried M, Neu R, Schalke B, von Susskind-Schwendi M, Sziklavari Z, Hofmann HS. Radical surgical resection of advanced thymoma and thymic carcinoma infiltrating the heart or great vessels with cardiopulmonary bypass support. J Cardiothorac Surg. 2015;10:137 (Epub 2015/10/31).PubMedPubMedCentral
59.
Wright CD. Extended resections for thymic malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S344–S347347 (Epub 2010/10/05).PubMed
60.
Shimizu N, Date H, Moriyama S, Ando A, Teramoto S. Reconstruction of the superior vena cava in patients with mediastinal malignancies. Eur J Cardiothorac Surg. 1991;5(11):575–8 (Epub 1991/01/01).PubMed
61.
62.
Sekine Y, Suzuki H, Saitoh Y, Wada H, Yoshida S. Prosthetic reconstruction of the superior vena cava for malignant disease: surgical techniques and outcomes. Ann Thorac Surg. 2010;90(1):223–8 (Epub 2010/07/09).PubMed
63.
Shintani Y, Ohta M, Minami M, Shiono H, Hirabayashi H, Inoue M, et al. Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors. J Thorac Cardiovasc Surg. 2005;129(4):809–12 (Epub 2005/04/12).PubMed
64.
Venuta F, Rendina EA, Klepetko W, Rocco G. Surgical management of stage III thymic tumors. Thorac Surg Clin. 2011;21(1):85–91 (vii, Epub 2010/11/13).PubMed
65.
Attaran S, Acharya M, Anderson JR, Punjabi PP. Does surgical debulking for advanced stages of thymoma improve survival? Interact Cardiovasc Thorac Surg. 2012;15(3):494–7 (Epub 2012/06/16).PubMedPubMedCentral
66.
Kuno H, Funaki S, Kimura K, Shimamura K, Kin K, Kuratani T, et al. Complete resection of local advanced thymic carcinoma with total aortic arch replacement after chemotherapy: a case report. Surg Case Rep. 2019;5(1):198 (Epub 2019/12/14).PubMedPubMedCentral
67.
Shintani Y, Shimamura K, Funaki S, Kimura K, Kin K, Kuratani T, et al. Combined aortic arch resection for lung cancer using total rerouting of supra-arch vessels. Ann Thorac Surg. 2019;107(6):e399–e401 (Epub 2018/12/05).PubMed
68.
Yamada Y, Yoshino I, Nakajima J, Miyoshi S, Ohnuki T, Suzuki M, et al. Surgical outcomes of patients with stage III thymoma in the Japanese Nationwide Database. Ann Thorac Surg. 2015;100(3):961–7 (Epub 2015/07/15).PubMed
69.
Yano M, Sasaki H, Moriyama S, Kawano O, Hikosaka Y, Masaoka A, et al. Preservation of phrenic nerve involved by stage III thymoma. Ann Thorac Surg. 2010;89(5):1612–9 (Epub 2010/04/27).PubMed
70.
Tokunaga T, Sawabata N, Kadota Y, Utsumi T, Minami M, Inoue M, et al. Efficacy of intra-operative unilateral diaphragm plication for patients undergoing unilateral phrenicotomy during extended surgery. Eur J Cardiothorac Surg. 2010;38(5):600–3 (Epub 2010/05/19).PubMed
71.
Kimura K, Kanzaki R, Kimura T, Kanou T, Ose N, Funaki S, et al. Long-term outcomes after surgical resection for pleural dissemination of thymoma. Ann Surg Oncol. 2019;26(7):2073–80 (Epub 2019/03/30).PubMed
72.
Hamaji M, Kojima F, Omasa M, Sozu T, Sato T, Chen F, et al. A meta-analysis of debulking surgery versus surgical biopsy for unresectable thymoma. Eur J Cardiothorac Surg. 2015;47(4):602–7 (Epub 2014/07/13).PubMed
73.
Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v40–55 (Epub 2015/09/01).PubMed
74.
Utsumi T, Shiono H, Kadota Y, Matsumura A, Maeda H, Ohta M, et al. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer. 2009;115(23):5413–20 (Epub 2009/08/18).PubMed
75.
Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, et al. The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thorac Oncol. 2017;12(4):734–44 (Epub 2017/01/28).PubMed
76.
Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso PL, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg. 2015;149(1):95–100 (1 e1–2, Epub 2014/12/20).PubMed
77.
Luo T, Zhao H, Zhou X. The clinical features, diagnosis and management of recurrent thymoma. J Cardiothorac Surg. 2016;11(1):140 (Epub 2016/09/02).PubMedPubMedCentral
78.
Mizuno T, Okumura M, Asamura H, Yoshida K, Niwa H, Kondo K, et al. Surgical management of recurrent thymic epithelial tumors: a retrospective analysis based on the Japanese nationwide database. J Thorac Oncol. 2015;10(1):199–205 (Epub 2014/09/24).PubMed
79.
Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60(4):908–13 (discussion 14, Epub 1995/10/01).PubMed
80.
Okumura M, Shiono H, Inoue M, Tanaka H, Yoon HE, Nakagawa K, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to world health organization histologic classification system. J Surg Oncol. 2007;95(1):40–4 (Epub 2006/12/29).PubMed
81.
Basse C, Thureau S, Bota S, Dansin E, Thomas PA, Pichon E, et al. Multidisciplinary tumor board decision making for postoperative radiotherapy in thymic epithelial tumors: insights from the RYTHMIC prospective cohort. J Thorac Oncol. 2017;12(11):1715–22 (Epub 2017/08/05).PubMed
82.
Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P. Thymoma: a focus on current therapeutic management. J Thorac Oncol. 2009;4(1):119–26 (Epub 2008/12/20).PubMed
83.
Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011;29(15):2060–5 (Epub 2011/04/20).PubMedPubMedCentral
84.
Zucali PA, De Pas T, Palmieri G, Favaretto A, Chella A, Tiseo M, et al. Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. J Clin Oncol. 2018;36(4):342–9 (Epub 2017/12/15).PubMed
85.
Giaccone G, Kim C, Thompson J, McGuire C, Kallakury B, Chahine JJ, et al. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol. 2018;19(3):347–55 (Epub 2018/02/06).PubMed
86.
Yamamoto Y, Iwahori K, Funaki S, Matsumoto M, Hirata M, Yoshida T, et al. Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors. Sci Rep. 2020;10(1):4064 (Epub 2020/03/07).PubMedPubMedCentral
87.
Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, et al. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer. 2019;7(1):319.PubMedPubMedCentral
Metadaten
Titel
Surgical management of thymic epithelial tumors
verfasst von
Yasushi Shintani
Soichiro Funaki
Naoko Ose
Takashi Kanou
Eriko Fukui
Kenji Kimura
Masato Minami
Publikationsdatum
10.07.2020
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 3/2021
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-020-02070-y

Weitere Artikel der Ausgabe 3/2021

Surgery Today 3/2021 Zur Ausgabe

Original Article

Early detection of infectious complications using C-reactive protein and the procalcitonin levels after laparoscopic colorectal resection: a prospective cohort study

How To Do It

Closure of enterotomy after side-to-side ileocolic anastomosis with two barbed sutures in totally laparoscopic colectomy for right-sided colon cancer

Original Article

Risk factors for outlet obstruction after laparoscopic surgery and diverting ileostomy for rectal cancer

Original Article

Inter-operative determination of the aortic root and cusp geometry associated with the aortic regurgitation grade

Original Article

A novel method for isolating lymphatic endothelial cells from lymphatic malformations and detecting PIK3CA somatic mutation in these isolated cells

Original Article

Prognostic impact of the preoperative hemoglobin A1c levels in patients with gastric cancer surgery depends on postoperative complications

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.